KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $115.0 billion.

  • Pfizer's Treasury Shares rose 21.87% to $115.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $115.0 billion, marking a year-over-year increase of 21.87%. This contributed to the annual value of $114.8 billion for FY2024, which is 24.11% up from last year.
  • As of Q3 2025, Pfizer's Treasury Shares stood at $3.9 billion, which was up 22.92% from $3.9 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Treasury Shares registered a high of $3.9 billion during Q1 2025, and its lowest value of $39.0 million during Q2 2022.
  • For the 5-year period, Pfizer's Treasury Shares averaged around $3.7 billion, with its median value being $3.9 billion (2023).
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 234.19% in 2022, then rose by 21.87% in 2025.
  • Over the past 5 years, Pfizer's Treasury Shares (Quarter) stood at $111.4 billion in 2021, then grew by 2.34% to $114.0 billion in 2022, then grew by 0.45% to $114.5 billion in 2023, then increased by 0.24% to $114.8 billion in 2024, then increased by 0.22% to $115.0 billion in 2025.
  • Its last three reported values are $115.0 billion in Q3 2025, $115.0 billion for Q2 2025, and $115.0 billion during Q1 2025.